v3.25.2
Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity - USD ($)
shares in Thousands, $ in Thousands
Common stock
Additional paid-in-capital
Accumulated deficit
Total
Beginning Balance at Dec. 31, 2023 $ 30 $ 534,060 $ (590,598) $ (56,508)
Beginning Balance (in shares) at Dec. 31, 2023 1,871      
Issuance of common stock, net of offering costs $ 4 3,705   3,709
Issuance of common stock, net of offering costs (in shares) 231      
Stock-based compensation   3,433   3,433
Issuance of stock purchase warrants   224   224
Issuance of pre-funded stock purchase warrants   3,570   3,570
Net Income (Loss)     (26,791) (26,791)
Ending Balance at Mar. 31, 2024 $ 34 544,992 (617,389) (72,363)
Ending Balance (in shares) at Mar. 31, 2024 2,102      
Beginning Balance at Dec. 31, 2023 $ 30 534,060 (590,598) (56,508)
Beginning Balance (in shares) at Dec. 31, 2023 1,871      
Issuance of stock purchase warrants       224
Net Income (Loss)       (35,090)
Ending Balance at Jun. 30, 2024 $ 40 551,347 (625,688) (74,301)
Ending Balance (in shares) at Jun. 30, 2024 2,524      
Beginning Balance at Mar. 31, 2024 $ 34 544,992 (617,389) (72,363)
Beginning Balance (in shares) at Mar. 31, 2024 2,102      
Issuance of common stock, net of offering costs $ 6 5,306   5,312
Issuance of common stock, net of offering costs (in shares) 419      
Stock-based compensation   1,057   1,057
Vesting of restricted stock units, net of employee tax obligations   (8)   (8)
Vesting of restricted stock units, net of employee tax obligations (in shares) 3      
Net Income (Loss)     (8,299) (8,299)
Ending Balance at Jun. 30, 2024 $ 40 551,347 (625,688) (74,301)
Ending Balance (in shares) at Jun. 30, 2024 2,524      
Beginning Balance at Dec. 31, 2024 $ 49 557,047 (650,197) $ (93,101)
Beginning Balance (in shares) at Dec. 31, 2024 3,102     3,102
Issuance of common stock, net of offering costs $ 10 471   $ 481
Issuance of common stock, net of offering costs (in shares) 2,358      
Stock-based compensation   180   180
Issuance of pre-funded stock purchase warrants   9,523   9,523
Vesting of restricted stock units, net of employee tax obligations   (1)   (1)
Vesting of restricted stock units, net of employee tax obligations (in shares) 8      
Net Income (Loss)     (7,254) (7,254)
Ending Balance at Mar. 31, 2025 $ 59 567,220 (657,451) (90,172)
Ending Balance (in shares) at Mar. 31, 2025 5,468      
Beginning Balance at Dec. 31, 2024 $ 49 557,047 (650,197) $ (93,101)
Beginning Balance (in shares) at Dec. 31, 2024 3,102     3,102
Issuance of stock purchase warrants       $ 0
Net Income (Loss)       (26,441)
Ending Balance at Jun. 30, 2025 $ 60 568,911 (676,638) $ (107,667)
Ending Balance (in shares) at Jun. 30, 2025 6,620     6,620
Beginning Balance at Mar. 31, 2025 $ 59 567,220 (657,451) $ (90,172)
Beginning Balance (in shares) at Mar. 31, 2025 5,468      
Issuance of common stock, net of offering costs $ 1 135   136
Issuance of common stock, net of offering costs (in shares) 1,146      
Stock-based compensation   1,556   1,556
Vesting of restricted stock units, net of employee tax obligations (in shares) 6      
Net Income (Loss)     (19,187) (19,187)
Ending Balance at Jun. 30, 2025 $ 60 $ 568,911 $ (676,638) $ (107,667)
Ending Balance (in shares) at Jun. 30, 2025 6,620     6,620